Avanza Fonder AB cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.0% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 67,879 shares of the healthcare conglomerate's stock after selling 12,897 shares during the period. UnitedHealth Group accounts for 1.2% of Avanza Fonder AB's portfolio, making the stock its 13th biggest position. Avanza Fonder AB's holdings in UnitedHealth Group were worth $35,514,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in the business. Financial Management Professionals Inc. boosted its stake in UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after buying an additional 17 shares during the last quarter. Richwood Investment Advisors LLC boosted its position in shares of UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after purchasing an additional 20 shares in the last quarter. Global Wealth Strategies & Associates lifted its position in UnitedHealth Group by 28.6% during the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after acquiring an additional 20 shares during the period. 44 Wealth Management LLC lifted its position in UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock worth $662,000 after acquiring an additional 21 shares during the period. Finally, Prentice Wealth Management LLC raised its stake in shares of UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate's stock valued at $1,278,000 after buying an additional 21 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on UNH. Bank of America lowered UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price target for the company from $560.00 to $350.00 in a research report on Wednesday, May 14th. Robert W. Baird cut UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target on the stock. in a research note on Wednesday. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Finally, Truist Financial reiterated a "buy" rating and set a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $426.52.
Check Out Our Latest Stock Report on UNH
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn purchased 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the purchase, the director now owns 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the transaction, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. This trade represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.28% of the stock is currently owned by insiders.
UnitedHealth Group Price Performance
Shares of NYSE UNH traded down $5.11 during trading on Friday, reaching $313.39. The company had a trading volume of 13,729,200 shares, compared to its average volume of 7,185,784. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a market cap of $284.28 billion, a PE ratio of 20.22, a PEG ratio of 1.37 and a beta of 0.45. The business's 50 day moving average price is $391.47 and its 200-day moving average price is $476.22. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the company posted $6.91 EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a $2.21 dividend. The ex-dividend date is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.82%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report